Scribd
Upload
67 views2 pages

AXB - Lab Developed Tests

Joint Commission Regulations as of 2024-08

Uploaded by

danielle.ziolo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
67 views2 pages

AXB - Lab Developed Tests

Joint Commission Regulations as of 2024-08

Uploaded by

danielle.ziolo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

Appendix B:

Laboratory Developed Tests


(AXB)

Laboratory Developed Tests


The US Food and Drug Administration (FDA) defines Laboratory Developed Tests
(LDTs) as “a class of in vitro diagnostics that are manufactured, including being
developed and validated, and offered, within a single laboratory.”
Historically, the components of LDTs were individually regulated by the FDA as
Analyte Specific Reagents (ASRs) or other specific or general reagents. Today, many
LDTs use complex elements and sophisticated technologies that may not be FDA-
regulated. Because the FDA does not actively regulate them, LDTs that have not been
properly validated for their intended use can result in missed diagnoses, wrong
diagnoses, and failure to receive appropriate treatment for patients.
Laboratories performing LDTs are currently regulated by the Clinical Laboratory
Improvement Amendments of 1988 (CLIA '88) by both proficiency and quality control
testing requirements.
For laboratories performing LDTs, follow the standards listed in the Molecular Biology
column of the Standards Applicability Grid (SAG), in addition to the following:
■ DC.02.01.05
■ DC.02.01.07
■ EC.02.04.05
■ HR.01.02.03, EP 4
■ QSA.02.04.01
■ QSA.02.10.01, EP 6
■ QSA.02.10.01, EP 7
■ QSA.02.10.03
■ QSA.04.01.01
■ QSA.04.02.01
■ QSA.04.03.01
■ QSA.04.04.01
Shading indicates a change effective July 1, 2024, unless otherwise noted in the What's New.
CAMLAB Update 1, July 2024 AXB – 1
E-dition July 1, 2024, Release
◤Comprehensive Accreditation Manual for Laboratory and Point-of-Care Testing

■ QSA.04.05.01
■ QSA.04.06.01
■ QSA.09.01.01
■ QSA.09.02.01
■ QSA.09.03.01
■ QSA.09.03.03
■ QSA.09.03.05
■ QSA.09.04.01
■ QSA.09.05.01
■ QSA.09.06.01
■ QSA.09.07.01
■ QSA.09.07.03
■ QSA.17.01.01
■ QSA.17.01.03
■ QSA.17.02.01
■ QSA.21.01.01
■ QSA.21.02.01
■ QSA.21.03.01
■ QSA.21.04.01

Shading indicates a change effective July 1, 2024, unless otherwise noted in the What's New.
AXB – 2 CAMLAB Update 1, July 2024
E-dition July 1, 2024, Release

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy